CoChat

Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma

Open access
Mansfield, Aaron S., Peikert, Tobias, Smadbeck, James B., Udell, Julia B.M., Garcia-Rivera, Enrique, Elsbernd, Laura, Erskine, Courtney L., Van Keulen, Virginia P., Kosari, Farhad, Murphy, Stephen J., Ren, Hongzheng, Serla, Vishnu V., Schaefer Klein, Janet L., Karagouga, Giannoula, Harris, Faye R., Sosa, Carlos, Johnson, Sarah H., Nevala, Wendy, Markovic, Svetomir N., Bungum, Aaron O., Edell, Eric S., Dong, Haidong, Cheville, John C., Aubry, Marie Christine, Jen, Jin, Vasmatzis, George · 2019 · Journal of Thoracic Oncology
Cited by 129

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Malignant pleural mesothelioma is a disease primarily associated with exposure to the carcinogen asbestos. Whereas other carcinogen-related tumors are associated with a high tumor mutation burden, mesothelioma is not. We sought to resolve this discrepancy. METHODS: We used mate-pair (n = 22), RNA (n = 28), and T cell receptor sequencing along with in silico predictions and immunologic assays to understand how structural variants of chromosomes affect the transcriptome. RESULTS: We observed that inter- or intrachromosomal rearrangements were present in every specimen and were frequently in a pattern of chromoanagenesis such as chromoplexy or chromothripsis. Transcription of rearrangement-related junctions was predicted to result in many potential neoantigens, some of which were proven to bind patient-specific major histocompatibility complex molecules and to expand intratumoral T cell clones. T cells responsive to these predicted neoantigens were also present in a patient's circulating T cell repertoire. Analysis of genomic array data from the mesothelioma cohort in The Cancer Genome Atlas suggested that multiple chromothriptic-like events negatively impact survival. CONCLUSIONS: Our findings represent the discovery of potential neoantigen expression driven by structural chromosomal rearrangements. These results may have implications for the development of novel immunotherapeutic strategies and the selection of patients to receive immunotherapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jtho.2018.10.001

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 129

Metadata

Authors
Mansfield, A. S., Peikert, T., Smadbeck, J. B., Udell, J. B. M., Garcia-Rivera, E., Elsbernd, L., Erskine, C. L., Van Keulen, V. P., Kosari, F., Murphy, S. J., Ren, H., Serla, V. V., Schaefer Klein, J. L., Karagouga, G., Harris, F. R., Sosa, C., Johnson, S. H., Nevala, W., Markovic, S. N., Bungum, A. O., Edell, E. S., Dong, H., Cheville, J. C., Aubry, M. C., Jen, J., & Vasmatzis, G.
Venue
Journal of Thoracic Oncology
Publisher
Elsevier BV
Published
2019-02
Volume
14
Issue
2
Pages
276-287
ISSN
1556-0864 (ISSN-L)
OpenAlex
W2897816153
Cited by
129
References
6
FWCI
10.82
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma. https://app.cochat.ai/papers/10.1016/j.jtho.2018.10.001
The paper
Mansfield, A. S., Peikert, T., Smadbeck, J. B., Udell, J. B. M., Garcia-Rivera, E., Elsbernd, L., Erskine, C. L., Van Keulen, V. P., Kosari, F., Murphy, S. J., Ren, H., Serla, V. V., Schaefer Klein, J. L., Karagouga, G., Harris, F. R., Sosa, C., Johnson, S. H., Nevala, W., Markovic, S. N., . . . Vasmatzis, G. (2019). Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2018.10.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.